Press release archive

Central Japan International Medical Center Highlighted Cancer Services for Overseas Patients

The Gifu hospital described proton therapy, preventive screening, and support for international visitors.

Minokamo, Gifu, Japan

Announcement

Central Japan International Medical Center promoted its cancer-care and international-patient services in May 2025. The hospital, which adopted its current name in 2022, is located in Minokamo, Gifu Prefecture. Its announcement described a proton therapy center, imaging and preventive-care services, and coordinators intended to help visitors navigate appointments and language needs.

The hospital's own English-language site confirms its location and medical-travel focus, while its proton therapy center describes a Varian ProBeam 360 system and treatment by appointment. Proton therapy is a form of radiation treatment whose appropriateness depends on cancer type, stage, prior care, and the available alternatives. The original release's broad claims about superiority, treatment speed, and lower costs abroad cannot be applied to every patient or compared fairly without an individualized plan and full cost estimate.

People considering cancer treatment overseas should obtain an independent oncology opinion, ask for evidence relevant to their diagnosis, and confirm clinical eligibility, travel fitness, payment, insurance, translation, and follow-up arrangements. Screening tests also have potential harms such as false positives and incidental findings. This hospital profile records the services advertised in 2025, not a recommendation to travel or a promise of clinical benefit.

Source and further information

Central Japan International Medical Center's official English-language hospital overview